<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">JAMA Dermatol</journal-id><journal-id journal-id-type="iso-abbrev">JAMA Dermatol</journal-id><journal-id journal-id-type="pmc-domain-id">3211</journal-id><journal-id journal-id-type="pmc-domain">jamasd</journal-id><journal-title-group><journal-title>JAMA Dermatology</journal-title></journal-title-group><issn pub-type="ppub">2168-6068</issn><issn pub-type="epub">2168-6084</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>JAMA Network</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12079565</article-id><article-id pub-id-type="pmcid-ver">PMC12079565.1</article-id><article-id pub-id-type="pmcaid">12079565</article-id><article-id pub-id-type="pmcaiid">12079565</article-id><article-id pub-id-type="pmid">40366644</article-id><article-id pub-id-type="doi">10.1001/jamadermatol.2025.1190</article-id><article-id pub-id-type="publisher-id">doi250016</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="category" specific-use="electronic"><subject>Research</subject></subj-group><subj-group subj-group-type="domain" specific-use="print"><subject>Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group><subj-group subj-group-type="featured" specific-use="electronic"><subject>Featured</subject></subj-group><subj-group subj-group-type="online-first"><subject>Online First</subject></subj-group><subj-group subj-group-type="allowCommenting"><subject>Comments</subject></subj-group></article-categories><title-group><article-title>Neighborhood Socioeconomic Status and New Hidradenitis Suppurativa Diagnoses in a Single Health System</article-title><alt-title alt-title-type="headline">Neighborhood Socioeconomic Status and New Hidradenitis Suppurativa Diagnoses</alt-title><alt-title alt-title-type="running-head">Neighborhood Socioeconomic Status and New Hidradenitis Suppurativa Diagnoses</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Chang</surname><given-names initials="AY">Aileen Y.</given-names></name><degrees>MD</degrees><xref rid="doi250016aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="doi250016aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="doi250016aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sanchez-Anguiano</surname><given-names initials="ME">Maria Elena</given-names></name><degrees>BS</degrees><xref rid="doi250016aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Supapannachart</surname><given-names initials="K">Krittin</given-names></name><degrees>MD</degrees><xref rid="doi250016aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Amerson</surname><given-names initials="EH">Erin H.</given-names></name><degrees>MD</degrees><xref rid="doi250016aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="doi250016aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Naik</surname><given-names initials="HB">Haley B.</given-names></name><degrees>MD</degrees><xref rid="doi250016aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="doi250016aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shiboski</surname><given-names initials="S">Stephen</given-names></name><degrees>PhD</degrees><xref rid="doi250016aff6" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Derouen</surname><given-names initials="MC">Mindy C.</given-names></name><degrees>PhD</degrees><degrees>MPH</degrees><xref rid="doi250016aff6" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yazdany</surname><given-names initials="J">Jinoos</given-names></name><degrees>MD</degrees><degrees>MPH</degrees><xref rid="doi250016aff7" ref-type="aff">
<sup>7</sup>
</xref></contrib></contrib-group><aff id="doi250016aff1"><label>1</label>Department of Dermatology, University of California, San Francisco School of Medicine, San Francisco</aff><aff id="doi250016aff2"><label>2</label>Department of Dermatology, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California</aff><aff id="doi250016aff3"><label>3</label>Viewpoint Editor, <italic toggle="yes">JAMA Dermatology</italic></aff><aff id="doi250016aff4"><label>4</label>University of California, Davis School of Medicine, Davis</aff><aff id="doi250016aff5"><label>5</label>Associate Editor, <italic toggle="yes">JAMA Dermatology</italic></aff><aff id="doi250016aff6"><label>6</label>Department of Epidemiology &amp; Biostatistics, University of California, San Francisco</aff><aff id="doi250016aff7"><label>7</label>Department of Medicine, Division of Rheumatology, University of California, San Francisco School of Medicine, San Francisco</aff><author-notes><title>Article Information</title><p><bold>Accepted for Publication:</bold> March 19, 2025.</p><p content-type="published-online"><bold>Published Online:</bold> May 14, 2025. doi:<uri content-type="doi">10.1001/jamadermatol.2025.1190</uri></p><corresp id="doi250016cor1"><bold>Corresponding Author:</bold> Aileen Y. Chang, MD, Department of Dermatology, San Francisco General Hospital, University of California, San Francisco, 995 Potrero, Building 90, Ward 92, San Francisco, CA 94110 (<email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="aileen.chang@ucsf.edu">aileen.chang@ucsf.edu</email>).</corresp><p content-type="author-contributions"><bold>Author Contributions:</bold> Drs Chang and Supapannachart had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.</p><p><italic toggle="yes">Concept and design:</italic> Chang, Sanchez-Anguiano, Supapannachart, Amerson, Naik, Hebert-DeRouen, Yazdany.</p><p><italic toggle="yes">Acquisition, analysis, or interpretation of data:</italic> Chang, Sanchez-Anguiano, Supapannachart, Shiboski, Hebert-DeRouen.</p><p><italic toggle="yes">Drafting of the manuscript:</italic> Chang, Shiboski.</p><p><italic toggle="yes">Critical review of the manuscript for important intellectual content:</italic> All authors.</p><p><italic toggle="yes">Statistical analysis:</italic> Chang, Supapannachart, Shiboski, Yazdany.</p><p><italic toggle="yes">Obtained funding:</italic> Chang.</p><p><italic toggle="yes">Administrative, technical, or material support:</italic> Chang, Sanchez-Anguiano.</p><p><italic toggle="yes">Supervision:</italic> Chang, Hebert-DeRouen, Yazdany.</p><p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Naik reported personal fees from AbbVie and personal fees from Medscape, Novartis, UCB, and Sonoma Biotherapeutics outside the submitted work; and serving as Vice President of the Hidradenitis Suppurativa Foundation. Dr Yazdany reported grants from Aurinia and personal fees from UCB and AstraZeneca outside the submitted work. No other disclosures were reported.</p><p content-type="funding-statement"><bold>Funding/Support:</bold> This project was supported by University of California San Francisco Academic Research Systems and by the US National Center for Advancing Translational Sciences of the National Institutes of Health (NIH; UCSF-CTSI grant No. KL2 TR001870. Dr Chang reports support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the NIH (award No. K23AR082918) during the conduct of this study. Dr Yazdany reports support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the NIH (award No. K24AR074534 and P30AR070155</p><p><bold>Role of the Funder/Sponsor:</bold> The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p><p><bold>Disclaimer:</bold> The manuscript contents are solely the responsibility of the authors and do not necessarily represent the official views of the University of California San Francisco or the NIH. Dr Chang is Viewpoint Editor and Dr Naik is Associate Editor of <italic toggle="yes">JAMA Dermatology</italic> but were not involved in any of the decisions regarding review of the manuscript or its acceptance.</p><p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-DOI250016-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p><p><bold>Additional Information:</bold> UCSF Versa, GPT-4o, version 2024-05-13, was used on December 9, 2024, to reduce the manuscript word count. The authors take responsibility for the integrity of the content generated.</p></author-notes><pub-date pub-type="epub" iso-8601-date="2025-05-14T10:00"><day>14</day><month>5</month><year>2025</year></pub-date><issue-id pub-id-type="pmc-issue-id">488624</issue-id><elocation-id>e251190</elocation-id><history><date date-type="received"><day>9</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>19</day><month>3</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>14</day><month>05</month><year>2026</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-05-16 00:25:17.170"><day>16</day><month>05</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright 2025 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies.</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jamadermatol-e251190.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf-version" xlink:href="jamadermatol-e251190.pdf">jamadermatol-e251190.pdf</self-uri><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="silverchair" xlink:href="https://jamanetwork.com/journals/archderm/fullarticle/10.1001/jamadermatol.2025.1190"/><abstract abstract-type="key-points"><title>Key Points</title><sec id="ab-doi250016-1"><title>Question</title><p>Is neighborhood-level socioeconomic status (SES) associated with a new diagnosis of hidradenitis suppurativa among dermatology patients?</p></sec><sec id="ab-doi250016-2"><title>Findings</title><p>This cross-sectional study of 65&#8201;766 dermatology patients in a single health system found that those residing in neighborhoods with lower SES had greater odds of a new hidradenitis suppurativa diagnosis compared to those in the highest-SES neighborhoods. The magnitude of the association was largest in patients residing in lowest-SES neighborhoods, and greater odds were observed among multiple racial and ethnic groups.</p></sec><sec id="ab-doi250016-3"><title>Meaning</title><p>These findings suggest that residing in a neighborhood with lower SES was associated with greater odds of a new diagnosis of hidradenitis suppurativa among dermatology patients.</p></sec></abstract><abstract><sec id="ab-doi250016-4"><title>Importance</title><p>Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition. Risk factors for developing HS (eg smoking and obesity) are influenced by social drivers of health at the neighborhood level. However, the association of neighborhood-level socioeconomic status (nSES) and HS has not been adequately assessed.</p></sec><sec id="ab-doi250016-5"><title>Objective</title><p>To evaluate the association of nSES with new HS diagnoses among dermatology patients within a single health system.</p></sec><sec id="ab-doi250016-6"><title>Design, Setting, and Participants</title><p>This was a cross-sectional study of patients of the dermatology clinics at the University of California San Francisco health system between August 1, 2019, and May 31, 2024, who were also residents of the San Francisco Bay Area at index visit. Data analyses were performed from June 1, 2024, to February 11, 2025.</p></sec><sec id="ab-doi250016-7"><title>Exposure</title><p>Census tract-level index measure of nSES that incorporated income, poverty, housing cost, rental cost, education, occupation, and employment. Quintiles of nSES were assigned based on nSES distribution in the San Francisco Bay Area counties.</p></sec><sec id="ab-doi250016-8"><title>Main Outcomes and Measures</title><p>A new HS diagnosis during the study period, identified by the <italic toggle="yes">International Statistical Classification of Diseases and Related Health Problems, Tenth Revision </italic>code, and confirmed by medical record review. Logistic regression models were constructed and fit by generalized estimating equations accounting for clustering by census tract with nSES quintile as the primary exposure (reference used was quintile 5, the highest nSES quintile); new HS diagnosis as the binary outcome; and age, sex, and race and ethnicity as confounders. In secondary analyses, smoking status, obesity, and health insurance type were assessed as possible mediators.</p></sec><sec id="ab-doi250016-9"><title>Results</title><p>The analyses included a total of 65&#8201;766 patients (mean [SD] age, 50.4 [18.3] years; 41.8% female), of whom 485 (0.7%) had a new HS diagnosis. Greater odds of a new HS diagnosis were observed in lower-SES neighborhoods (Q1-Q4)&#8212;after adjusting for age, sex, and race and ethnicity, odds ratio for Q1 was 3.32 (95% CI, 2.46-4.49); Q2, 2.25 (95% CI, 1.62-3.12); Q3, 1.97 (95% CI, 1.46-2.66); and Q4, 1.44 (95% CI, 1.06-1.96) (<italic toggle="yes">P</italic> &lt;.001 [linear trend]). In race-stratified analyses, greater odds of a new HS diagnosis were observed among patients residing in lower-SES neighborhoods, although this pattern did not reach statistical significance at the 5% level in all racial and ethnic groups.</p></sec><sec id="ab-doi250016-10"><title>Conclusions and Relevance</title><p>This cross-sectional study found that nSES was independently associated with a new diagnosis of HS among dermatology patients. This finding supports the hypothesis that neighborhood-level factors may influence the development of HS.</p></sec></abstract><abstract abstract-type="teaser" specific-use="electronic"><p>This cross-sectional study evaluates the of neighborhood socioeconomic status with new hidradenitis suppurativa diagnoses within a single health system.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-exception-type</meta-name><meta-value>EMBARGO</meta-value></custom-meta><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>4</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>no</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>